Iceutica Operations Company Profile
✉ Email this page to a colleague
What is the competitive landscape for ICEUTICA OPERATIONS
ICEUTICA OPERATIONS has one approved drug.
There are three US patents protecting ICEUTICA OPERATIONS drugs.
Summary for Iceutica Operations
| US Patents: | 3 |
| Tradenames: | 1 |
| Ingredients: | 1 |
| NDAs: | 1 |
Drugs and US Patents for Iceutica Operations
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Iceutica Operations | VIVLODEX | meloxicam | CAPSULE;ORAL | 207233-002 | Oct 22, 2015 | DISCN | Yes | No | 9,649,318 | ⤷ Start Trial | Y | ⤷ Start Trial | |||
| Iceutica Operations | VIVLODEX | meloxicam | CAPSULE;ORAL | 207233-001 | Oct 22, 2015 | DISCN | Yes | No | 9,649,318 | ⤷ Start Trial | Y | ⤷ Start Trial | |||
| Iceutica Operations | VIVLODEX | meloxicam | CAPSULE;ORAL | 207233-001 | Oct 22, 2015 | DISCN | Yes | No | 9,526,734 | ⤷ Start Trial | Y | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Paragraph IV (Patent) Challenges for ICEUTICA OPERATIONS drugs
| Drugname | Dosage | Strength | Tradename | Submissiondate |
|---|---|---|---|---|
| ➤ Subscribe | Capsules | 5 mg and 10 mg | ➤ Subscribe | 2017-01-09 |
International Patents for Iceutica Operations Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| South Korea | 20170017915 | ⤷ Start Trial |
| Uruguay | 36172 | ⤷ Start Trial |
| South Africa | 201700022 | ⤷ Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
